SHL Telemedicine Past Earnings Performance
Past criteria checks 0/6
SHL Telemedicine's earnings have been declining at an average annual rate of -42.8%, while the Healthcare industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 9.3% per year.
Key information
-42.8%
Earnings growth rate
-43.9%
EPS growth rate
| Healthcare Industry Growth | 13.4% |
| Revenue growth rate | 9.3% |
| Return on equity | -12.3% |
| Net Margin | -15.8% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Market Cool On SHL Telemedicine Ltd.'s (VTX:SHLTN) Revenues Pushing Shares 27% Lower
Oct 10
Investors Give SHL Telemedicine Ltd. (VTX:SHLTN) Shares A 32% Hiding
Aug 21Market Participants Recognise SHL Telemedicine Ltd.'s (VTX:SHLTN) Revenues Pushing Shares 30% Higher
Jun 04SHL Telemedicine Ltd. (VTX:SHLTN) Not Lagging Industry On Growth Or Pricing
Apr 20We Think SHL Telemedicine Ltd.'s (VTX:SHLTN) CEO Compensation Package Needs To Be Put Under A Microscope
Dec 01Is SHL Telemedicine (VTX:SHLTN) A Risky Investment?
Oct 28Is SHL Telemedicine (VTX:SHLTN) Using Debt In A Risky Way?
Jun 23SHL Telemedicine Ltd.'s (VTX:SHLTN) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Mar 05Are SHL Telemedicine's (VTX:SHLTN) Statutory Earnings A Good Guide To Its Underlying Profitability?
Feb 12What Percentage Of SHL Telemedicine Ltd. (VTX:SHLTN) Shares Do Insiders Own?
Jan 21Investors Who Bought SHL Telemedicine (VTX:SHLTN) Shares A Year Ago Are Now Up 120%
Jan 04
What Do The Returns At SHL Telemedicine (VTX:SHLTN) Mean Going Forward?
Dec 01Revenue & Expenses Breakdown
How SHL Telemedicine makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 56 | -9 | 27 | 5 |
| 31 Mar 24 | 57 | -8 | 27 | 5 |
| 31 Dec 23 | 57 | -7 | 27 | 5 |
| 30 Sep 23 | 57 | -5 | 28 | 5 |
| 30 Jun 23 | 57 | -2 | 28 | 4 |
| 31 Mar 23 | 58 | -1 | 28 | 4 |
| 31 Dec 22 | 59 | 0 | 28 | 4 |
| 30 Sep 22 | 59 | -2 | 27 | 3 |
| 30 Jun 22 | 59 | -4 | 26 | 3 |
| 31 Mar 22 | 55 | -9 | 24 | 3 |
| 31 Dec 21 | 50 | -14 | 22 | 3 |
| 30 Sep 21 | 46 | -12 | 20 | 3 |
| 30 Jun 21 | 42 | -10 | 19 | 3 |
| 31 Mar 21 | 41 | -5 | 18 | 3 |
| 31 Dec 20 | 40 | 0 | 17 | 3 |
| 30 Sep 20 | 40 | 1 | 16 | 3 |
| 30 Jun 20 | 40 | 2 | 15 | 3 |
| 31 Mar 20 | 41 | 4 | 15 | 3 |
| 31 Dec 19 | 42 | 6 | 15 | 3 |
| 30 Sep 19 | 42 | 6 | 15 | 3 |
| 30 Jun 19 | 42 | 5 | 16 | 3 |
| 31 Mar 19 | 45 | 8 | 16 | 3 |
| 31 Dec 18 | 49 | 10 | 15 | 3 |
| 30 Sep 18 | 49 | 10 | 15 | 3 |
| 30 Jun 18 | 48 | 9 | 15 | 3 |
| 31 Mar 18 | 43 | 6 | 15 | 3 |
| 31 Dec 17 | 37 | 2 | 15 | 3 |
| 30 Sep 17 | 37 | -1 | 16 | 3 |
| 30 Jun 17 | 36 | -5 | 17 | 4 |
| 31 Mar 17 | 36 | -8 | 18 | 4 |
| 31 Dec 16 | 36 | -11 | 19 | 4 |
| 30 Sep 16 | 36 | -15 | 20 | 3 |
| 30 Jun 16 | 36 | -20 | 21 | 3 |
| 31 Mar 16 | 39 | -19 | 22 | 3 |
| 31 Dec 15 | 39 | -16 | 21 | 3 |
| 30 Sep 15 | 40 | -8 | 19 | 3 |
| 30 Jun 15 | 40 | 1 | 19 | 2 |
| 31 Mar 15 | 39 | 2 | 18 | 3 |
| 31 Dec 14 | 40 | 1 | 20 | 2 |
| 30 Sep 14 | 39 | 4 | 19 | 2 |
| 30 Jun 14 | 36 | 3 | 18 | 2 |
| 31 Mar 14 | 33 | 3 | 16 | 2 |
| 31 Dec 13 | 30 | 2 | 14 | 2 |
Quality Earnings: SHLTN is currently unprofitable.
Growing Profit Margin: SHLTN is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SHLTN is unprofitable, and losses have increased over the past 5 years at a rate of 42.8% per year.
Accelerating Growth: Unable to compare SHLTN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SHLTN is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (14.3%).
Return on Equity
High ROE: SHLTN has a negative Return on Equity (-12.27%), as it is currently unprofitable.